Abstract
Test-negative designs (TNDs) can be used to estimate vaccine effectiveness by comparing the relative rates of the target disease and symptomatically similar diseases among vaccinated and unvaccinated populations. However, the diagnostic tests used to identify the target disease typically suffer from imperfect sensitivity and specificity, leading to biased vaccine effectiveness estimates. Here we present a solution to this problem via a Bayesian statistical model which can either incorporate point estimates of test sensitivity and specificity, or can jointly infer them directly from laboratory validation data. This approach enables uncertainties in the performance characteristics of the diagnostic test to be correctly propagated to estimates, avoiding both bias and false precision in vaccine effectiveness. By further incorporating individual covariates of study participants, and by allowing data streams from multiple diagnostic test types to be rigorously combined, our approach provides a flexible model for the analysis of TNDs with explicitly stated assumptions.
Competing Interest Statement
R.K. received consulting fees from Partners In Health. M.L. received grants from US CDC, NIH/NIGMS, NIH/NIAID, and UK National Institute for Health Research, and Pfizer, and consulting fees or honoraria from Merck, Sanofi Pasteur, Janssen, and Bristol Myers Squibb. E.K.J., Y.H.G., and D.B.L. declare no competing interests.
Funding Statement
This work was supported in part by the SeroNet program of the National Cancer Institute (1U01CA261277-01), and by the Morris-Singer Fund for the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All code needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials, and open-source code is available at https://github.com/erikj540/Bayesian-Vaccine-Efficacy. The Bayesian models were implemented in the programming language STAN which we called through Python 3.8.
